Gene-drug interactions (data source: DGIdb)
Gene Name Entrez ID Drug Name Chembl ID Interaction Types Sources publications

Variant-drug associations (data source: PharmGKB)
Gene Name Variant Alleles Chemical Phenotype Category Significance Notes Sentence Publications Annotation ID
PTPN22 rs2476601 A adalimumab efficacy no Allele A is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G. 23007924 981417521
PTPN22 rs2476601 GG rituximab efficacy no No significant association was seen between genotype and whether a patient was a "responder" or a "non-responder". "Responders" had a post-rituximab disease activity score (DAS28) of lower than 5.1 and a DAS28 variation between baseline and post-treatment higher than 0.6. Please note alleles have been complemented to the plus chromosomal strand. Genotype GG is not associated with response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AA + AG. 22129793 982047084
PTPN22 rs2476601 AA + AG leflunomide toxicity no Over the first 12 months of leflunomide treatment, there was no statistically significant relationship between carrying the T allele and cessation of leflunomide treatment due to side effects. Please note that alleles have been complemented to the plus chromosomal strand. Genotypes AA + AG is not associated with discontinuation of leflunomide in people with Arthritis, Rheumatoid as compared to genotype GG. 25040563 1445296386
PTPN22 rs2476601 A Tumor necrosis factor alpha efficacy no using either the absolute change in DAS28 or the proportion of good responders and non-responders as outcomes. Allele A is not associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G. 25834819 1444702654
PTPN22 rs2476601 AA + AG leflunomide efficacy no Over the first 12 months of leflunomide treatment, there was no statistically significant relationship between carrying the T allele and change in 28-joint Disease Activity Score (DAS28; used to assess clinical response). Please note that alleles have been complemented to the plus chromosomal strand. Genotypes AA + AG is not associated with response to leflunomide in people with Arthritis, Rheumatoid as compared to genotype GG. 25040563 1445296375